Gastroenterology Doctors in Gastonia, NC Accepting Medicare

7 Gastroenterology doctors found. Showing 1 - 7

Suresh Khandekar, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2544 Court Dr Ste G, Gastonia, NC 28054 Phone: 704-854-9990

Chang Kyeong Oh, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2544 Court Dr Ste G, Gastonia, NC 28054 Phone: 704-854-9990    Fax: 704-854-9045

William J Caddick, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2544 Court Dr, Ste H, Gastonia, NC 28054 Phone: 704-854-9990    Fax: 704-854-9045

Paul Youngbok Oh, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2544 Court Dr Ste G, Gastonia, NC 28054 Phone: 704-854-9990    Fax: 704-854-9045

Neville Washington Forbes, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2664 Court Drive, Suite A, Gastonia, NC 28054 Phone: 704-861-9030    Fax: 704-833-1234

Henry L. Danis Iii, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2544 Court Dr, Ste H, Gastonia, NC 28054 Phone: 704-854-9990    Fax: 704-854-9045

Vikas Narayan Chitnavis, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2525 Court Dr, Gastonia, NC 28054 Phone: 704-834-2000    Fax: 704-834-2500

News Archive

New study documents symptoms of people before they acquire multiple sclerosis

During the five years before people develop the first clinically recognized signs of multiple sclerosis, they are up to four times more likely to be treated for nervous system disorders such as pain or sleep problems, and are 50 per cent more likely to visit a psychiatrist, according to new research from the University of British Columbia.

Phase II trial of Impax Pharmaceuticals' Parkinson's disease drug candidate successful

Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (NASDAQ: IPXL) today reported the positive results from a recently completed Phase II trial of its late-stage Parkinson's Disease drug candidate IPX066

FDA approves Mylan's generic Dexrazoxane for Injection ANDA

Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Dexrazoxane for Injection, packaged in 250 mg and 500 mg Single-use Vials. This product is the generic version of Pharmacia & Upjohn's Zinecard® for Injection, a chemoprotective agent.

OrPro to advance development of ORP-100 for treatment of cystic fibrosis

OrPro Therapeutics, Inc. today announced that the company has been awarded a National Heart, Lung and Blood Institute Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).

HHS awards ICF International $11.7M contract under CDC task order

ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a new $11.7 million contract by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC). The contract has a term of three years. The contract is awarded under a CDC National Center for Birth Defects and Developmental Disabilities ID/IQ task order.

Read more Medical News

› Verified 8 days ago